User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

Primary tabs

download
  • Open access
  • PDF
  • 214.57 K
Kyselovic, J Krenek, Peter [UCL] Wibo, Maurice [UCL] Godfraind, Theophile [UCL]

1. Calcium channel blockers (CCBs) are anti-hypertensive drugs that are usually considered to act mainly as vasodilators. We investigated the relation between the reduction of blood pressure evoked by two long-acting CCBs and their protective effect against cardiac and renal damage in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). 2. SHRSP were exposed to high dietary salt intake (1% NaCl in drinking solution) from 8 to 14 weeks of age, with or without amlodipine or lacidipine at three dosage regimens producing similar effects on blood pressure. 3. The lowest dosages of both drugs had non-significant effects on blood pressure but inhibited the paradoxical increases in plasma renin activity (PRA) and in renin mRNA in kidney that were found in salt-loaded SHRSP. The lowest dosage of lacidipine (but not of amlodipine) restored the physiological downregulation of renin production by high salt and reduced left ventricular hypertrophy and mRNA levels of atrial natriuretic factor and transforming growth factor-beta1. 4. The intermediate dosages reduced blood pressure and PRA in a comparable manner, but cardiac hypertrophy was more reduced by lacidipine than by amlodipine. 5. Although the highest doses exhibited a further action on blood pressure, they had no additional effect on cardiac hypertrophy, and they increased PRA and kidney levels of renin mRNA even more than in the absence of drug treatment. 6. We conclude that reduction of blood pressure is not the sole mechanism involved in the prevention of cardiac remodelling by CCBs, and that protection against kidney damage and excessive renin production by low and intermediate dosages of these drugs contributes to their beneficial cardiovascular effects.

  1. Border W. A., Noble N. A., Interactions of Transforming Growth Factor-  and Angiotensin II in Renal Fibrosis, 10.1161/01.hyp.31.1.181
  2. CAMPBELL, Cardiovasc. Res., 27, 1350 (1993)
  3. COMINACINI, J. Hypertens., 15, 1633 (1997)
  4. CRESPI, Neurosci. Lett., 298, 171 (2001)
  5. Cristofori P., Micheli D., Terron A., Gaviraghi G., Lacidipine : Experimental Evidence of Vasculoprotective Properties, 10.1097/00005344-199423005-00019
  6. DE CHAMPLAIN, J. Hypertens., 16, 1357 (1998)
  7. Ding Y., Vaziri N. D., Calcium Channel Blockade Enhances Nitric Oxide Synthase Expression by Cultured Endothelial Cells, 10.1161/01.hyp.32.4.718
  8. Dostal D. E., Baker K. M., The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function?, 10.1161/01.res.85.7.643
  9. EPSTEIN, J. Hypertens., 16, S17 (1998)
  10. Feron Olivier, Salomone Salvatore, Godfraind Théophile, Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats, 10.1111/j.1476-5381.1996.tb15451.x
  11. FOGARI, J. Hypertens., 18, 1871 (2000)
  12. GILBERT, Curr. Opin. Pharmacol., 1, 183 (2001)
  13. GODFRAIND, Pharmacol. Ther., 64, 37 (1994)
  14. GRIFFIN, Am. J. Hypertens., 14, 311 (2001)
  15. Hempel A., Lindschau C., Maasch C., Mahn M., Bychkov R., Noll T., Luft F. C., Haller H., Calcium Antagonists Ameliorate Ischemia-Induced Endothelial Cell Permeability by Inhibiting Protein Kinase C, 10.1161/01.cir.99.19.2523
  16. ITO, J. Clin. Invest., 92, 398 (1993)
  17. KAZDA, J. Hypertens., 5, S37 (1987)
  18. KIM, Pharmacol. Rev., 52, 11 (2000)
  19. KIM, J. Pharmacol. Exp. Ther., 273, 509 (1995)
  20. Kim Shokei, Ohta Kensuke, Hamaguchi Akinori, Yukimura Tokihito, Miura Katsuyuki, Iwao Hiroshi, Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats, 10.1111/j.1476-5381.1996.tb15437.x
  21. Krenek P., Salomone S., Kyselovic J., Wibo M., Morel N., Godfraind T., Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats, 10.1161/01.hyp.37.4.1124
  22. KURTZ, Am. J. Physiol., 275, F849 (1998)
  23. KYSELOVIC, J. Hypertens., 16, 1515 (1998)
  24. MATSUMORI, Life Sci., 67, 2655 (2000)
  25. MATSUNAGA MASATO, YAMAMOTO JIN, HARA AKIRA, YAMORI YUKIO, OGINO KOICHI, OKAMOTO KOZO, PLASMA RENIN AND HYPERTENSIVE VASCULAR COMPLICATIONS : AN OBSERVATION IN THE STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RAT, 10.1253/jcj.39.1305
  26. Muller D. N., Dechend R., Mervaala E. M. A., Park J.-K., Schmidt F., Fiebeler A., Theuer J., Breu V., Ganten D., Haller H., Luft F. C., NF- B Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats, 10.1161/01.hyp.35.1.193
  27. Muller D. N., Fischli W., Clozel J.-P., Hilgers K. F., Bohlender J., Menard J., Busjahn A., Ganten D., Luft F. C., Local Angiotensin II Generation in the Rat Heart : Role of Renin Uptake, 10.1161/01.res.82.1.13
  28. NAKAMURA, Kidney Int., 55, S109 (1996)
  29. Napoli C., Salomone S., Godfraind T., Palinski W., Capuzzi D. M., Palumbo G., D'Armiento F. P., Donzelli R., de Nigris F., Capizzi R. L., Mancini M., Gonnella J. S., Bianchi A., Chan P. H., 1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats   Editorial Comment, 10.1161/01.str.30.9.1907
  30. ROTH, Proc. Natl. Acad. Sci. U.S.A., 93, 5478 (1996)
  31. Schricker Karin, Hamann Marlies, Macher Andreas, Krämer Bernhard K., Kaissling Brigitte, Kurtz Armin, Effect of amlodipine on renin secretion and renin gene expression in rats, 10.1111/j.1476-5381.1996.tb15735.x
  32. SHARMA, Biochem. Biophys. Res. Commun., 205, 105 (1994)
  33. SHIBOTA, Am. J. Physiol., 236, H409 (1979)
  34. SHIN, Kidney Int., 54, 1617 (1998)
  35. Stier C. T., Benter I. F., Ahmad S., Zuo H. L., Selig N., Roethel S., Levine S., Itskovitz H. D., Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke- prone spontaneously hypertensive rats, 10.1161/01.hyp.13.2.115
  36. SUSIC, J. Hypertens., 17, 1209 (1999)
  37. SUZUKI, Eur. J. Pharmacol., 228, 269 (1993)
  38. URSINI, J. Cardiovasc. Pharmacol., 30, S28 (1997)
  39. Volpe M., Camargo M. J., Mueller F. B., Campbell W. G., Sealey J. E., Pecker M. S., Sosa R. E., Laragh J. H., Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats, 10.1161/01.hyp.15.3.318
  40. ZANNAD, Am. J. Hypertens., 9, 633 (1996)
  41. Zhang X., Hintze T. H., Amlodipine Releases Nitric Oxide From Canine Coronary Microvessels : An Unexpected Mechanism of Action of a Calcium Channel Blocking Agent, 10.1161/01.cir.97.6.576
Bibliographic reference Kyselovic, J ; Krenek, Peter ; Wibo, Maurice ; Godfraind, Theophile. Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.. In: British journal of pharmacology, Vol. 134, no. 7, p. 1516-22 (2001)
Permanent URL http://hdl.handle.net/2078.1/8998